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Abstract Important physiological actions of somatostatin are
mediated by the somatostatin receptor type 2. Its transcription is
regulated by three tissue specific, alternative promoters. It is
known that the mRNA of the somatostatin receptor type 2 gene
is induced by cAMP, but little is known about the mechanisms
underlying this regulation. We have identified and characterized
a cAMP responsive element located at nucleotide 3162 on the
second promoter of the gene consisting of the classical
palindromic octameric sequence 5P-TGACGTCA-3P. Using
transient expression of reporter gene deletion constructs in
NG108-15 cells the necessity of the intact element for forskolin-
induced reporter gene activity was demonstrated. The first and
the third promoter are not responsive to forskolin, nor did any
promoter respond to the phorbol ester PMA. Electrophoretic
mobility shift assays in combination with competition experi-
ments suggest the interaction of the promoter element with the
cAMP responsive element binding protein.
z 1998 Federation of European Biochemical Societies.
Key words: Somatostatin receptor 2; cAMP responsive
element; Transcription regulation
1. Introduction
Somatostatin was initially isolated from ovine hypothalamic
extracts as an inhibitor of growth hormone release from cul-
tured pituitary cells [1]. Later, it became evident that soma-
tostatin exerts diverse biological functions in many other tis-
sues, for example the inhibition of insulin and glucagon
release from pancreas [2], paracrine inhibition of gastric acid
secretion [3] and neurotransmission and neuromodulation in
the central nervous system [4].
The cellular actions of somatostatin are mediated by ¢ve
distinct types of G protein coupled somatostatin receptors
(sst1^5) [5^12]. Sst2 is alternatively spliced into two di¡erent
receptor isoforms, a long (sst2A), and a short (sst2B) variant
[13]. The structure of the mouse sst2 gene was recently ana-
lyzed by our group: the gene contains two previously unrec-
ognized exons, separated by large introns. The ¢rst three
exons are preceded by individual promoters, which are in-
volved in tissue speci¢c expression of the sst2 gene. The sec-
ond promoter in front of exon 2 seems to be the main pro-
moter, since it is used in tissues in which somatostatin has
important functions such as brain, pituitary and pancreas.
In addition, it contains a putative cAMP responsive response
element (CRE) with the consensus sequence 5P-TGACGTCA-
3P [14]. A previous study has shown that the expression of sst2
mRNA can be induced by the second messenger cAMP [15].
Classically, elevation of intracellular cAMP levels leads to an
activation of protein kinase A (PKA). The activated catalytic
subunit of PKA enters the cell nucleus, where the cAMP
response element binding protein (CREB) is activated by
phosphorylation. Binding of phosphorylated CREB to a
CRE within a promoter results in enhanced transcription of
the gene (for review see [16]). In this report we demonstrate
the functionality of the putative CRE of the sst2 promoter
using transient transfection experiments and electrophoretic
mobility shift assays (EMSA).
2. Materials and methods
2.1. Promoter constructs
For reporter gene constructs the chloramphenicol acetyltransferase
(CAT) gene containing reporter plasmid pBLCAT2 [17] was used.
Promoter sequences were inserted into the vector by simultaneously
replacing the thymidine kinase promoter of pBLCAT2 with sst2 gene
promoter sequences. Three series of sst-CAT reporter gene constructs
were cloned with the following sst2 sequences: (i) a 672-bp PstI/StuI
fragment including the ¢rst promoter and 247 bp of exon1 (P1-425),
(ii) a 1318-bp SacI/XhoI insert containing the promoter 5P of exon2
and 181 bp transcribed sequences (P2-1137), and (iii) a 640-bp SacI
fragment including the transcription start site within exon3 (P3-572).
Deletion constructs were made by cutting and religating sst-CAT-
plasmids with appropriate enzymes or with the method described by
Lin et al. [18]. The CRE deletion P2-1137v3606/341 was obtained by
deletion of a 561-bp SacII fragment and religation of the vector. For
P2-1137vCRE, P2-1137 was cut with AatII, a restriction enzyme
which recognizes the central 6 bp of the CRE, then the cohesive
ends were removed by T4 DNA polymerase and ¢nally the plasmid
was religated, turning the original 5P-TGACGTCA-3P into 5P-TGCA-
3P.
2.2. Cell culture
NG108-15 cells were cultured at 37‡C with 10% CO2 in Dulbecco’s
modi¢ed Eagle’s medium containing 10% fetal calf serum, 100 units/
ml penicillin, 100 mg/ml streptomycin, and HAT (0.1 mM hypoxan-
thine, 10 WM aminopterin, 17 WM thymidine).
2.3. Transfection and CAT assay
For transfections 1U106 cells were plated on 5-cm tissue culture
dishes and allowed to grow for 4^6 h. Then medium was replaced and
cells were transfected with 8 Wg plasmid DNA using a calcium phos-
phate method as described in Chen and Okayama [19]. After 16^18 h
medium was renewed again and cells were allowed to grow for 48 h
before harvesting. Harvesting and CAT ELISA were performed ac-
cording to the protocol of the CAT ELISA kit from Boehringer
Mannheim.
2.4. Nuclear protein extraction
NG108-15 cells were harvested in cold phosphate bu¡ered saline
(PBS) and collected in a 50-ml plastic tube. The cells were pelleted
and washed once in cold PBS. The volume of the pellet (PCV) was
estimated and the cells were resuspended in 5U PCV bu¡er A (10 mM
HEPES-KOH, pH 7.6, 10 mM KCl, 0.15 mM spermine/HCl, 0.5 mM
spermidine, 1 mM EDTA, 0.5 mM DTT). During an incubation of at
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least 10 min on ice, the cells were checked under microscope to ensure
swelling of the cells. The cells were centrifuged at 800Ug and 0‡C for
5 min and resuspended in 2U PCV of bu¡er A. The cells were broken
in a Dounce homogenizer by several strokes with a tight pestle, which
was also monitored under microscope. When 90% of the cells were
broken, one-tenth volume of bu¡er A-iso (10 mM HEPES-KOH, pH
7.6, 100 mM KCl, 0.15 mM spermine/HCl, 0.5 mM spermidine, 1 mM
EDTA, 0.5 mM DTT) was added, mixed gently and then pelleted with
1100Ug and 0‡C for 10 min. The pelleted crude nuclei were resus-
pended in 2.5 ml/109 used cells nuclear lysis bu¡er (10 mM HEPES-
KOH, pH 7.6, 100 mM KCl, 3 mM MgCl2, 0.1 mM EDTA, 10%
glycerol, 1 mM DTT). The suspension was put in an ice-water bath,
and one-tenth volume of 4 M (NH4)2SO4 was added dropwise and
stirred for 30 min. After centrifugation at 90 000Ug and 0‡C for 40
min, the supernatant was recovered, put on a magnetic stirrer and in
ice-water bath, and 0.3 g/ml of solid (NH4)2SO4 was added slowly.
After another centrifugation (90 000Ug, 0‡C, 25 min) the pellet was
carefully resuspended in one-tenth PCV of dialysis bu¡er (25 mM
HEPES-KOH, pH 7.6, 40 mM KCl, 0.1 mM EDTA, 10% glycerol,
1 mM DTT). The nuclear extract was dialyzed twice against 200 ml
dialysis bu¡er at 4‡C (average pore diameter, 24 Aî ), frozen in aliquots
in liquid nitrogen, and stored at 380‡C.
2.5. Electrophoretic mobility shift assay
Synthetic oligonucleotides (MWG Biotech, Ebersberg, Germany)
carrying putative transcription factor binding sites were labeled with
[Q-32P]ATP (Amersham, Braunschweig, Germany) according to stand-
ard methods [20]. For each reaction 5000 cpm labeled probe DNA
was incubated with 2 Wl NG108-15 cell nuclear extract for 30 min at
room temperature in a 20-Wl reaction mixture containing 10 mM Tris,
pH 7.5, 50 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% glycerol and
1 Wg poly(dI-dC) DNA. Some reactions also contained various
amounts of competitor DNA. Samples were loaded onto 6% poly-
acrylamide gels and separated electrophoretically. The gels were dried
and exposed to Kodak X-Omat AR ¢lms.
2.6. Statistical analysis
For statistical evaluation Student’s t-tests were performed. Stars (*)
indicate signi¢cantly di¡erent values (P6 0.05).
3. Results and discussion
Recently, the complete 5P regulatory region of the sst2 gene
has been characterized, identifying three promoters as shown
in Fig. 1A [14]. The three promoters (P1^3) were assayed in
transiently transfected NG108-15 cells. This was done (i) to
test the putative CRE on the second promoter and (ii) to
exclude the possibility that other promoter elements mediate
a cAMP response, as was shown for AP-1 [21,22] and AP-2
[23].
First, basal CAT activities of reporter gene constructs of
P1^P3 were compared to the reporter gene activity under
control of the herpes simplex virus thymidine kinase promoter
(pBLCAT2), which was de¢ned as 100% (Fig. 1B). For the
P1-425 construct an activity of 109%, for P2-1137 161% and
for P3-572 118% was observed. Then CAT activities for all
constructs were measured after stimulation with forskolin (1
WM). No signi¢cantly altered CAT activities could be detected
for constructs carrying sequences of the ¢rst and third pro-
moter (P1-425 and P3-572). Testing the putative CRE bearing
second promoter P2-1137, a 2.2-fold signi¢cant induction of
CAT activity was observed after forskolin administration, in-
dicating the involvement of the putative CRE in cAMP in-
duced transcription. For further characterization of this e¡ect,
a series of 5P deletions of the second promoter (P2-181, P2-85)
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Fig. 1. A: Genomic organization of the sst2 gene. Exons are shown as boxes, translated parts of the exons are shaded, transmembrane domains
I^VII are indicated. Lines represent intronic sequences. Three transcription initiation sites are indicated as arrows. A putative CRE within the
second promoter is depicted. B: Functional analysis of the sst2 promoter. NG108-15 cells were transiently transfected with sst2-CAT reporter
gene constructs designated after the respective promoter (P1, P2, P3). Numbering of the reporter genes is according to the transcription initia-
tion site (arrows) of the respective promoter. The CRE within the second promoter is indicated (¢lled box). Basal CAT activities (open bars)
and activities after forskolin stimulation (1 WM, dashed bars) are expressed relative to that of pBLCAT2 which contains the herpes simplex thy-
midine kinase (tk) promoter. Data are shown as the mean þ S.E.M. of at least three independent experiments performed in duplicate.
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was prepared. The P2-181 deletion, which still contains the
CRE, exhibited a 3.0-fold induced CAT activity in response
to forskolin. In contrast, after deletion of the CRE sequence
(P2-85) the CAT activities remained on basal levels after stim-
ulation, indicating that the putative CRE sequence is func-
tional. To provide further evidence for involvement of the
CRE, two additional deletions were cloned, which should
show that no other sequences than the CRE could mediated
the forskolin induced e¡ect. In P2-1137v3606/341 the CRE
and adjacent regions were deleted, whereas in P2-1137vCRE
only the CRE was destroyed by eliminating four nucleotides
within the CRE sequence, leaving the rest of the promoter
intact. Both constructs showed no altered CAT activities after
stimulation. Taken together, these results clearly demonstrate
that the CRE within the second promoter of the sst2 gene is
the functional element, responsive for the forskolin induced
transcriptional activation.
These results are consistent with data published by Patel et
al. [15], who reported an induction of sst2 mRNA levels after
forskolin stimulation of AtT-20 mouse pituitary cells. Inter-
estingly, the authors showed in their experiments that only the
shorter form of two detected mRNA transcripts (2.3 kb, 2.8
kb) was upregulated, speculating that this was the spliced
variant sst2B. It is not possible to align the 2.3-kb transcript
to a speci¢c promoter or splice variant due to alternative
promoter usage, 3P alternative splicing and varying length of
poly(A) tails. One band seen in Northern blot experiments
may thus contain several mRNA species. However, these re-
sults are in good accordance with our ¢ndings that not all
mRNA species of sst2 are induced by forskolin but only those
deriving from the second promoter. Whereas sst2 mRNA is
induced by forskolin, no induction can be detected after PMA
stimulation either in Northern blots [15] or in our transfection
experiments (data not shown).
Electrophoretic mobility shift assay was used to character-
ize interactions of nuclear proteins with the sst2-CRE (Fig.
2A). Incubation of the sst2 CRE with NG108-15 cell nuclear
extract resulted in a typical ‘band shift’ (lane 1). The shifted
complex was speci¢cally competed by the unlabeled sst2 CRE
oligonucleotide (lanes 2 and 3). A similar competition oc-
curred when using an unlabeled somatostatin CRE oligonu-
cleotide or an unlabeled oligonucleotide with a CRE consen-
sus sequence (lanes 4^7; for nucleotide (nt) sequences see Fig.
2B). For the CRE within the somatostatin gene the binding of
CREB was clearly demonstrated previously [24]. Considering
the competition pattern, it must be assumed that the same
nuclear protein binds to all used oligonucleotides, which is
most likely CREB.
The cAMP/CREB signalling pathway is an important com-
mon mechanism used by many cells and tissues to regulate the
expression of a variety of target genes. Interestingly, sst genes
are upregulated in many tumor cells. Sst2 is especially highly
expressed in meningiomas, neuroblastomas, pituitary adeno-
mas, small cell lung carcinomas, lymphomas, and breast tu-
mors [25,26]. The upregulation of sst genes might be consid-
ered as a kind of protective mechanism of the cell by
rendering it susceptible to antiproliferative action of somatos-
tatin. This property of stable analogs of somatostatin is used
to treat a variety of tumors [27]. In this context one may
imagine sst ‘manipulation’ (arti¢cial up-regulation) [28] in tu-
mor tissue which may be achieved for example via the cAMP/
CREB pathway investigated here.
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